SCHEMBL28488686

SCHEMBL28488686

N=C(N=C(N)N1CCC(F)(F)CC1)Nc1ccc(Cl)c(Cl)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.43
CHRM2 P08172 1/20 0.41
HTR1A P08908 1/20 0.41
ADRA2A P08913 1/20 0.41
ADRA2B P18089 1/20 0.41
ADRA2C P18825 1/20 0.41
DRD1 P21728 1/20 0.41
SLC6A2 P23975 1/20 0.41
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41
SLC6A4 P31645 1/20 0.41
ADRA1A P35348 1/20 0.41
OPRM1 P35372 1/20 0.41
HTR2B P41595 1/20 0.41
SLC6A3 Q01959 1/20 0.41
KCNH2 Q12809 1/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28499778 0.99 HTT (0.42) HTTCHRM2HTR1AADRA2AADRA2B
SCHEMBL28509027 0.91 MAPT (0.46) HTTMEN1KMT2ALMNAHPGD
Hydrochloric Acid SCHEMBL28489288 0.90 MAPT (0.45) HTTMEN1KMT2ALMNAHPGD
SCHEMBL28496363 0.90 HTT (0.34) HTTCHRM2HTR1AADRA2AADRA2B
SCHEMBL23035174 0.86 NPC1 (0.56) HTTCHRM2HTR1AADRA2AADRA2B
SCHEMBL23035199 0.85 NPC1 (0.58) HTTCHRM2HTR1AADRA2AADRA2B
Hydrochloric Acid SCHEMBL23035301 0.85 NPC1 (0.55) HTTCHRM2HTR1AADRA2AADRA2B
Hydrochloric Acid SCHEMBL23035341 0.84 NPC1 (0.57) HTTCHRM2HTR1AADRA2AADRA2B
SCHEMBL28903652 0.83 EPHX2 (0.35) EPHX2
SCHEMBL28494641 0.83 NAMPT (0.35) HTTCHRM2HTR1AADRA2AADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107635963-B Guanidine compounds and uses thereof 伊谬诺米特医疗有限公司 2020-11-20 CN disclosed